- Research article
- Open Access
A role for prenylated rab acceptor 1 in vertebrate photoreceptor development
BMC Neuroscience volume 13, Article number: 152 (2012)
The rd1 mouse retina is a well-studied model of retinal degeneration where rod photoreceptors undergo cell death beginning at postnatal day (P) 10 until P21. This period coincides with photoreceptor terminal differentiation in a normal retina. We have used the rd1 retina as a model to investigate early molecular defects in developing rod photoreceptors prior to the onset of degeneration.
Using a microarray approach, we performed gene profiling comparing rd1 and wild type (wt) retinas at four time points starting at P2, prior to any obvious biochemical or morphological differences, and concluding at P8, prior to the initiation of cell death. Of the 143 identified differentially expressed genes, we focused on Rab acceptor 1 (Rabac1), which codes for the protein Prenylated rab acceptor 1 (PRA1) and plays an important role in vesicular trafficking. Quantitative RT-PCR analysis confirmed reduced expression of PRA1 in rd1 retina at all time points examined. Immunohistochemical observation showed that PRA1-like immunoreactivity (LIR) co-localized with the cis-Golgi marker GM-130 in the photoreceptor as the Golgi translocated from the perikarya to the inner segment during photoreceptor differentiation in wt retinas. Diffuse PRA1-LIR, distinct from the Golgi marker, was seen in the distal inner segment of wt photoreceptors starting at P8. Both plexiform layers contained PRA1 positive punctae independent of GM-130 staining during postnatal development. In the inner retina, PRA1-LIR also colocalized with the Golgi marker in the perinuclear region of most cells. A similar pattern was seen in the rd1 mouse inner retina. However, punctate and significantly reduced PRA1-LIR was present throughout the developing rd1 inner segment, consistent with delayed photoreceptor development and abnormalities in Golgi sorting and vesicular trafficking.
We have identified genes that are differentially regulated in the rd1 retina at early time points, which may give insights into developmental defects that precede photoreceptor cell death. This is the first report of PRA1 expression in the retina. Our data support the hypothesis that PRA1 plays an important role in vesicular trafficking between the Golgi and cilia in differentiating and mature rod photoreceptors.
Retinitis pigmentosa (RP) is the leading cause of inherited blindness. In recent years, progress has been made in the identification of genetic defects and molecular mechanisms that underlie RP [1, 2]. The rd1 mouse is among the best-characterized animal models of RP [3, 4]. It is distinguished by early onset and rapid degeneration of rod photoreceptors with cell death beginning around postnatal day 10 (P10), during the period of photoreceptor differentiation, and completed by P21 . Cone cell degeneration occurs slowly over the following year [5, 6]. The rd1 mutation is autosomal recessive, occurring in the β-subunit of the rod-specific cGMP phosphodiesterase6 (Pde6b) gene [7, 8]. The defect in Pde6 causes a failure in the hydrolysis of cGMP, resulting in a doubling of cytoplasmic cGMP levels by P6 in rd1 whole retina compared to wild type (wt) and a nearly 10-fold increase by P13 [3, 9].
cGMP is an important second messenger involved in regulation of many functions including phototransduction as well as neuronal differentiation, smooth muscle contractility, and olfactory stimulation . In the outer segment of a mature normal photoreceptor, cGMP facilitates the opening of ion channels permeable to sodium leading to depolarization of the cell. These channels are also permeable to calcium, which may play several roles including negative feedback of cGMP. In the rd1 retina, photoreceptors degenerate just as the outer segment begins to form. Although the significance of cGMP in phototransduction is well established, little is known about the role of cGMP in developing photoreceptors or how it leads to degeneration in the rd1 retina.
We have used microarray analysis to investigate differences in gene expression between the rd1 and wt mouse retinas during the period preceding cell death from P2, prior to any identified morphological or biochemical differences, through P8, when early degenerative changes are present but prior to onset of cell death. During this period, 143 differentially expressed genes were identified. We confirmed two genes to be differentially expressed at all 4 time points: the mutant gene, PDE6b, and Rab acceptor 1 (prenylated) (Rabac1). Rabac1 codes for an integral membrane protein, PRA1, that interacts with numerous small prenylated GTPases in the Rab family [11–14], consistent with a role in vesicular trafficking. The specific function of PRA1 in photoreceptors, however, has not been elucidated.
Here we present the first description of PRA1 in the retina, establishing the localization of PRA1 protein in developing wt and rd1 mouse retinas. We demonstrate that its expression in photoreceptors is significantly decreased and mislocalized in rd1 retina compared to wt, prior to rod photoreceptor degeneration and consistent with a role of PRA1 in rod differentiation.
Identification of differentially expressed genes
Gene expression profiles of rd1 mouse retina were compared to those of wt retina at four time points: P2, P4, P6, and P8. This time span was selected such that the earliest time point precedes any reported morphological or biochemical changes in rd1 retina compared to wt and the latest time point precedes onset of cell death. At least four samples were examined for microarray analysis at each time point. Genes that showed 1.5 fold or greater change, with False Discovery Rate Confidence Interval (FDR-CI) p-values less than 1 were included, resulting in the identification of 143 differentially expressed genes in rd1 compared to wt retina between P2 and P8 (Additional file 1: Table S1). Of these genes, 106 were downregulated and 43 were upregulated at one or more time points. Only 6 genes, all in the crystallin family, were included in both groups. These 6 genes were upregulated at P8 but downregulated at P6, and in one case also at P4.
Characterization of functional groups
Functional groups of differentially expressed genes were derived from gene ontology (GO) terms (Figure 1). Analysis identified approximately two-thirds of the differentially expressed genes to be associated with only six functional categories: cell cycle, development (including crystallins), metabolism, signal transduction, transcription, and transport. Consistent with the timing of retinal degeneration in the rd1 mouse, only 2 genes associated with apoptosis were differentially expressed at early developmental ages, whereas most genes associated with visual transduction were differentially expressed only at the later time points, P6 or P8.
Functional analysis shows differences in genes identified at P2 compared to P8 (Figure 2). At P2, forty-five genes were downregulated, of which 24% were associated with metabolism, 18% with transport, and 9% each with transcription, development, and signal transduction (Figure 2A). All differentially expressed genes at P2 were down regulated. Forty-two genes were differentially expressed at P8, three-quarters of which were downregulated (Figure 2B). Of the genes downregulated at P8, 26% were associated with transport, 13% with signal transduction, and 10% with metabolism. Genes associated with cell adhesion and visual perception, not seen at P2, comprise another 13% and 10% of downregulated genes, respectively. Fewer genes associated with transcription and development were identified at P8 compared to P2. More than half of the upregulated genes were members of the crystallin family that were not observed at P2, consistent with previous studies demonstrating upregulation of retinal crystallins in the degenerating rd1 retina [15, 16].
Quantitative analysis of differentially expressed genes
Quantitative real-time PCR (qPCR) was used to validate microarray results for 18 genes at one or more time points (Additional file 1: Table S2, Figure 3). Nearly all of the tested genes that were identified as differentially expressed in the microarray were confirmed by qPCR. However, some genes not detected in the microarray results were found to be differentially expressed at additional time points, consistent with the greater sensitivity of this technique. Of the genes that were analyzed, only two genes were significantly downregulated at all developmental time points examined: the rd1 mutant gene, Pde6b, (Figure 3A) and Rabac1 (Figure 3B). Rabac1 was downregulated by a factor of 2–3 fold at all four time points. Its protein product, PRA1, was clearly observed in wt retina at P2 and P4 by Western blot analysis (Figure 4), but was greatly reduced in rd1 retinas at P2 and P4 (13% and 30% of wt P4, respectively). PRA1 has not previously been investigated in the retina and was selected for further studies.
Localization of PRA1 in developing wt and rd1retinas
We used an immunohistochemical approach to determine the localization of PRA1 protein in wt and rd1 mouse retinal tissue at four time points during development: P6, P8, P10, and P21. At all ages examined, no PRA1-like immunoreactivity (LIR) was observed when the primary antibody was omitted (Figures 5A, D, G, J). PRA1-LIR was localized to the perinuclear region, associated with the Golgi apparatus, of most inner retinal neurons in all ages of the wt retina. At P6, this was most apparent in the ganglion cell layer (GCL), with staining progressively more intense in the nuclear layers at P8 and P10. Punctate labeling was also seen throughout both plexiform layers (Figure 5).
In the outer retina at P6, the wt retina appeared to have brighter and more defined PRA1-LIR in developing inner segments compared to a fainter and more diffuse pattern in the rd1 inner segments (IS; Figure 5B, C). A noticeable streaking pattern of PRA1-LIR through the distal portion of the outer nuclear layer (ONL) to the region of the developing IS was also seen, which correlates with the timing of growth and differentiation of the photoreceptor apical processes. This streaking pattern was much more defined in the wt compared to rd1 retina and, at higher magnification, appeared to be a chain of small vesicle-like punctae (Figure 5, insets). No differences in PRA1-LIR were seen in the inner retinal layers of wt compared to rd1 retinas.
At P8, in both wt and rd1 retinas, PRA1 staining appeared more intense compared to corresponding tissue at P6. Overall at P8, the rd1 retina appeared to have fainter PRA1-LIR compared to wt tissue (Figure 5E, F). PRA1-LIR appeared more intense in the proximal half of the IS layer of wt retina with more diffuse PRA1-LIR in the distal IS (Figure 5E). No comparable distinction was seen in the rd1 retina with large PRA1-LIR punctae distributed diffusely throughout the IS region (Figure 5F). As observed at P6, the streaking pattern of PRA1-LIR through the ONL to the IS region was present, but to a greater degree in P8 retina. In the P8 wt retina, the streaks appeared longer and more defined (Figure 5E) while in the streaks in the rd1 retina appeared shorter in length and less intense (Figure 5F). The inner retina of both wt and rd1 tissue appeared to have the same general pattern of PRA1-LIR with intense staining in the perinuclear space of ganglion cells and some INL cells as well as punctate staining throughout the INL. PRA1-LIR punctae were seen throughout the outer plexiform layer (OPL) and more diffusely in the inner plexiform layer (IPL).
PRA1-LIR in P10 tissue appeared similar to that at P8, with a few notable differences (Figure 5H, I). As above, P10 wt tissue was overall brighter in appearance when compared to the rd1 age-matched tissue. Intense PRA1-LIR could be observed in the proximal half of the IS layer with more diffuse label extending throughout the distal portion of the IS layer (Figure 5H). The intense PRA1-LIR observed in the proximal half of the wt IS layer was absent in the rd1 IS layer. Instead, only diffuse PRA1-LIR was observed in the IS layer of rd1 mouse retina (Figure 5I). The P10 wt retina, like the P8 wt retina, had a clearly delineated streaking pattern of PRA1-LIR from the ONL to the IS margin. In contrast, the PRA1-LIR streaking pattern was less intense in P10 rd1 retina compared to age-matched wt retina, although it was more distinct compared to P8 rd1 retinas. By P10, PRA1-LIR in the INL was concentrated at the perinuclear region of most cells with punctate staining still apparent in the OPL. No difference was seen between wt and rd1 in the inner retina.
In P21 wt retina, intense PRA1-LIR was observed at the proximal margin of the IS layer, where photoreceptor Golgi membranes reside, with moderately intense PRA1-LIR in the distal IS layer. The OS layer appeared to include sparse PRA1-LIR with little staining in the OPL compared to P10 retinas (Figure 5K). The streak-like pattern seen in the ONL at younger ages was not present in the mature P21 retina. The pattern of PRA1-LIR in the inner retina appeared similar to P10. Perinuclear staining was apparent in most INL cells. PRA1-LIR showed a similar pattern of staining in the surviving inner retina of age-matched rd1 littermates at P21. However, the ganglion cell layer (GCL) of rd1 retina at P21 appeared to have less intense PRA1-LIR in the perinuclear region compared to wt (Figure 5L). In addition to perinuclear staining still present in the INL of the rd1 retina, PRA1-LIR was present in processes throughout the INL. Diffuse punctae were also seen throughout the IPL. The residual ONL, containing cone cell nuclei, had little PRA1-LIR, while the area distal to the remaining ONL had a few areas of bright punctae exhibiting PRA1-LIR in the region of residual cone IS.
Relationship of PRA1-LIR to Golgi and cilia
Because Golgi apparatus is localized to the proximal IS of photoreceptors and is disrupted during rd1 photoreceptor differentiation , we double labeled P10 retinas with PRA1 and the cis-Golgi marker, GM-130. No crossreactivity was seen between the antibodies, although nonspecific labeling of blood vessels was observed with mouse monoclonal GM-130 staining (Figure 6A). In wt retinas, GM-130-LIR intensely labeled the developing inner segment at the border of the ONL (Figure 6B). PRA1-LIR colocalized with GM-130-LIR at the IS margin, although the Golgi marker was more extensive. In contrast, no overlap was seen in the distal portion of the IS where PRA1-LIR was distributed diffusely. The punctate streak-like pattern that was observed with PRA1-LIR in the ONL appeared as a continuous line labeled with both markers: some segments single labeled with each marker and some double labeled segments. This streak-like pattern is consistent with the migration of Golgi from the perinuclear region to the IS during photoreceptor differentiation. In the inner retina, intense GM-130 staining was localized in the perinuclear region of most cells and, in a few cases, in processes within the INL. Most PRA1-LIR overlapped with the Golgi marker, although some PRA1-LIR fine processes and punctae in both plexiform layers and diffuse label within somata at the outer margin of the INL were negative for GM-130-LIR. Conversely, GM-130-LIR appeared more extensive than PRA1 staining in the perinuclear region of many cells. The overall pattern of GM-130-LIR was similar in double labeled P10 rd1 retinas except in the IS region (Figure 6C). GM-130-LIR was distributed more extensively with both single and double labeled punctae in the distal portion of the rd1 IS (Figure 6C, inset), which was never seen in the wt.
PRA1 has been shown to interact with Rab6 [11–13], which is also associated with Golgi and post-Golgi trafficking of rhodopsin . Because available antibodies to PRA1 and Rab6 were raised in the same species, cross-reactivity prevented colocalization using immunohistochemical techniques. However, double labeling of Rab6-LIR with GM-130-LIR at P10 showed close apposition of the two markers with minimal overlap in either wt or rd1 photoreceptors (Figure 6E, F), as might be expected from their predicted localization to trans- and cis-Golgi, respectively . Rab6-LIR had a punctate appearance, consistent with a vesicular pattern. Similar to GM-130-LIR, Rab6-LIR was limited to the inner portion of the IS in the wt retina, but extended apically through the entire IS in the rd1 retina.
In order to determine whether PRA1 localization extends through the photoreceptor cilia, P21 wt retinas were double labeled with antibodies against PRA1 and RP1, a microtubule associated protein present in the OS portion of the photoreceptor axoneme [20, 21]. PRA1-LIR punctae were often observed in close apposition to RP1-LIR (Figure 6H, arrow), with little or no RP1-LIR colocalization. Sparse PRA1 punctae were seen, however, in the OS beyond RP1-LIR (Figure 6H, arrowheads). No label was detected in control experiments omitting primary antibodies (Figure 6G).
Quantitative analysis of PRA1-LIR
At all time points, PRA1-LIR appeared more intense in the wt outer retina than in the rd1 retina. In order to confirm this observation, we performed quantitative analysis using Image J software to determine the average intensity of the IS layer for littermate pairs of wt and rd1 tissue. For all developmental time points examined, the average PRA1-LIR intensity of the IS layer in wt tissue increased with age and was greater than that of the age-matched rd1 IS layer intensity (Figure 7A). Less PRA1-LIR was observed in the IS layer of rd1 retinas when compared to littermate wt retinas at all ages, although variability precluded significance at P6. To determine whether differential expression of PRA1 was limited to the outer retina, we also looked at the average intensity of PRA1-LIR in the inner plexiform layer (IPL) at each developmental time point. In this analysis we found that the average intensity of PRA1-LIR was very similar in wt and rd1 retinas with some difference seen only at P8 (Figure 7B).
The rd1mouse is a model of retinal degeneration
The rd1 mouse retina has been of interest as a model of inherited retinal degenerative diseases since it was first identified in 1924 . The initial molecular trigger in the rd1 retina, defective PDE6β leading to increased cGMP, is well understood [3, 7, 8]. The final events that underlie cell death have been the target of many investigations (reviewed in ). A virtual black box obscures the molecular processes that link these two events. In order to investigate the earliest events that are downstream of the Pde6b mutation in rd1 photoreceptors, we selected time points starting at P2, which is more than a week after Pde6b gene expression but prior to any identified biochemical or morphological differences, and concluding at P8, prior to the initiation of photoreceptor cell death.
Previous studies in rd1 whole retina during this time window have shown that the cytoplasmic cGMP level is twice the wt level by P6 with an increase of nearly 10-fold by P13 [3, 9]. Electron microscopical studies [17, 23, 24] have identified abnormal pathology in the rd1 retina, including retardation of IS growth as early as P4 , Golgi disruption by P6, and formation of widespread scattered vacuole-like structures by P8 . The mitochondrial matrix begins to disintegrate in photoreceptor IS by P6-8, in some cases prior to the appearance of outer segment disks [17, 23, 24]. At the rod ribbon synapse, a normal dyad configuration is formed with horizontal cells at P7, but the triad configuration incorporating a bipolar process seen in the wt retina at P8 fails to form in the rd1 retina .
Our microarray analysis of differentially expressed genes during this early time frame identified only 2 of 143 genes associated with apoptosis, consistent with our effort to target the earliest molecular changes that may provide the initial trigger for degeneration. Several studies using microarray analysis of rd1 retina at later time points, focusing on initiation of cell death, have been previously reported [25–27]. Using cluster analysis to investigate temporal patterns in groups of genes, Rohrer and colleagues identified differential expression beginning by P10 [25, 26]. Hackam, et al. identified temporally distinct pathways by comparing peak rod degeneration at P14 to early (P35) and later (P50) cone degeneration . Genes involved in transport mechanisms and signaling pathways were differentially expressed at P14 as well as in our study at earlier time points.
The link between the mutant gene and rd1pathology remains poorly understood
cGMP regulates the cGMP-gated (CNG) ion channel in the mature retina, which regulates Ca2+ and Na+ entry in response to light. Efforts to measure Ca2+ in the degenerating rd1 retina have provided support for the hypothesis that the loss of function of Pde6β induces apoptosis as a result of high levels of Ca2+ influx through the CNG ion channel [3, 28, 29]. This hypothesis is further supported by experiments in which loss of functional CNG channels slows the degeneration in Pde6b mutants [30, 31].
Several observations raise the question as to whether Pde6β may play an unexplored role in photoreceptor development, independent of its role in phototransduction in the mature retina, and whether such a role could contribute to the initiation of cell death. First, Pde6b is expressed at embryonic day 12 (E12) in the mouse retina, much earlier than other genes involved in phototransduction, such as rhodopsin expression that becomes apparent at P5. Pde6b is even expressed prior to Nrl, a transcription factor that activates expression of rod-specific genes and is expressed at P1 . Interestingly, Pde6a and Pde6g are first expressed more than a week after Pde6b at P1 , suggesting that any possible role that Pde6β might play during embryonic development may be through an atypical structural conformation. Other members of the PDE family, including the cone PDE6α’, function as homodimers. The inhibitory gamma subunits are unique to the PDE6 subfamily. Further research is needed to explore the possibility that PDE6β could play a functional role during early photoreceptor development, possibly by forming a homodimer.
Secondly, the doubling of cGMP levels in whole rd1 retina by P6 [3, 9] indicates that Pde6β is functional in wt retina prior to this age, a time at which expression of rhodopsin and other genes associated with phototransduction is first initiated . In addition, pathological changes described above can be observed prior to outer segment differentiation and prior to expression of genes required for assembly of the phototransduction machinery. Finally, although best known in the retina for its role in phototransduction, cGMP is an important signaling molecule throughout the CNS. It functions in signaling pathways involved in neuronal differentiation and gene expression, modulation of neurotransmitter release, learning and memory, brain seizure activity, and neurotoxicity [33–37]. cGMP is known to act on three signaling pathways: cGMP-gated ion channels, inhibitory feedback onto Pde, and activation of phosphokinase G (PKG). Increased phosphorylation of PKG substrates has been observed in the rd1 retina compared to the wt retina at P11, consistent with multiple signaling roles for cGMP in the retina . Although specific substrates for PKG have not been clearly identified in photoreceptors , signaling through PKG is known to regulate gene transcription .
Together, these observations support the hypothesis that Pde6β plays a role in regulation of cGMP signaling during pre- and/or early postnatal photoreceptor differentiation that is independent of its role in phototransduction in the mature outer segment. Our analysis of functional groups of the differentially regulated genes supports this hypothesis. First, only 7 of the differentially expressed genes, excluding the mutant gene, were associated with visual transduction, and most of these were only expressed at the later time points. Secondly, the differentially expressed genes are predominantly in functional groups that are consistent with a role in development and differentiation, including development, transport, cell cycle, signal transduction, transcription, and metabolism. Transport is particularly important during photoreceptor differentiation as the cell must transport membranes and proteins in order to elongate both its axon and inner segment, followed by assembly of the outer segment. Within this category, we identified Rabac1, which was of particular interest as the only gene in the dataset other than the mutant Pde6b gene, identified as downregulated at all four time points examined.
PRA1 is important for vesicular trafficking
PRA1, the protein product of Rabac1, is comprised of 185 amino acids and an estimated molecular mass of 20.6 kDa [11, 12, 40]. Structural studies have identified two integral membrane domains , although fractionation studies have localized PRA1 to both the cytoplasm and the Golgi complex [11, 14, 41, 42]. PRA1 interacts with numerous small GTPases, all of which are prenylated [11–14] and has been proposed to play a role in vesicular trafficking.
Martincic et al.  hypothesized that PRA1 might function in vesicular docking and fusion based on its initial binding partners, Rab3a and VAMP2. Since this initial study five specific hypotheses have been proposed. The observation that PRA1 binds to prenylated GTPases and occurs as a cytoplasmic protein suggested that PRA1 might act as an escort protein, transporting prenylated GTPases through the cell by masking the prenyl moiety . Secondly, PRA1 may function as a Golgi sorting protein by facilitating the insertion of small GTPases into the membranes of transport vesicles and instructing them where to go in the cell . Sivars and colleagues  proposed a third function of PRA1 as a guanine nucleotide dissociation inhibitor (GDI) displacement factor (GDF) that aids in recycling Rabs during vesicular trafficking. An additional role for PRA1 in lipid transport, modulation of lipid homeostasis, and cell migration has been proposed based on proteomic analysis of PRA1 depleted nasopharyngeal carcinoma cells  and further supported by studies implicating PRA1 in the fusion of transport vesicles with the plasma membrane . Finally, evidence supports a role for PRA1 in transport and assembly of viral proteins, although in some cases it may play an inhibitory role [45–49]. These proposed functions for PRA1 are in no way mutually exclusive and in many cases are overlapping.
PRA1 is significantly downregulated during early photoreceptor differentiation in the rd1retina
We present here the first report describing the expression and localization of PRA1 protein in the developing and mature wt and rd1 mouse retinas. In the developing wt retina, colocalization with GM-130-LIR indicates that PRA1 is localized to the photoreceptor Golgi apparatus as it translocates from the perikarya to the proximal IS during photoreceptor differentiation. PRA1 is also inferred to be in proximity with Rab6 during photoreceptor differentiation. Diffuse PRA1-LIR that does not colocalize with the Golgi marker is seen in the distal IS of wt photoreceptors starting at P8. In the mature retina, PRA1 positive punctae extend up to, but not overlapping with, the proximal end of the OS axoneme as labeled by RP1-LIR. Only very sparse punctae are seen in the OS. Both plexiform layers also contain PRA1 positive punctae independent of GM-130 staining during postnatal retinal development. In the wt OPL, PRA1-LIR appears less intense at P21, suggesting that it may play a role in neurite outgrowth and/or synapse formation that is not required for maintenance in the adult. This observation is of particular interest in light of the failure of the rd1 rod photoreceptors to form a triad synapse with bipolar dendrites . Together, these observations are consistent with a role for PRA1 in vesicular and lipid trafficking from the Golgi to vesicles directed both toward the cilia and the synapse. PRA1-LIR also colocalizes with the Golgi marker in the perinuclear region of most cells in the GCL and the INL.
By both Western blot at P2-P4 and immunohistochemistry at P6-P21, PRA1 expression appears less intense in rd1 compared to age-matched, wt retinas. Mislocalization of PRA1-LIR in the IS layer is seen in the rd1 retina at all ages examined. Compared to wt, rd1 retinas display a less intense, diffuse pattern of staining in the IS with some large punctae distributed throughout. Colocalization of PRA1- and GM-130-LIR is seen in some, but not all, of these IS punctae. This observation is consistent with EM pathology in the rd1 retina showing defects characteristic of vesicular trafficking [17, 23, 24].
In developing mouse retina, the decrease in PRA1-LIR in the rd1 IS layer compared to wt is apparent at all ages examined, and is statistically different by P8. Staining in the residual rd1 outer retina at P21 suggests that PRA1-LIR is also present in cone photoreceptors. The PRA1-LIR intensity in the perinuclear region of the rd1 GCL is also reduced at P21, consistent with a possible role of PRA1 in neurite remodeling and sprouting. Virtually all of the proteins altered in PRA1-depleted nasopharyngeal carcinoma cells that are linked to changes in cell migration  are also known to be important in neurite outgrowth. In the inner retina we found similar average intensities of PRA1-LIR at all time points examined except at P8, most likely an anomalous result due to small sample size. This suggests that the 2–3 fold reduction in Rabac1 mRNA measured by qPCR in whole retina is largely due to loss of expression in photoreceptors, with less overall change in protein expression in the inner retina.
PRA1 may play a role in vesicular trafficking during photoreceptor differentiation
Rod photoreceptors are highly specialized cells that exhibit unambiguous cellular polarity. Polarity of these cells is established during cell differentiation and maintained by the sorting of lipid membranes and proteins to their appropriate targets through a process of vesicular trafficking. Using Xenopus as a model system, four members of the Rab GTPase family, Rab3, Rab6, Rab8, and Rab11, have been identified in vesicular trafficking of rhodopsin from the Golgi to the connecting cilium at the base of the outer segments . Two of these, Rab3 and Rab6, bind directly to PRA1 in yeast two hybrid screens [11–13]. Rab proteins have also been highlighted in proteomics analyses of the bovine rod outer segment  and of the mouse photoreceptor sensory cilium complex . These studies have focused on maintenance of the mature photoreceptor cell. Whether the same Rabs play a role in vesicular sorting during photoreceptor development has not yet been explored.
Defects in vesicular trafficking have been implicated in retinal degenerative diseases. Mutation in Rab escort protein 1, a protein responsible for modifying small GTPases, has been linked to choroideremia, a disease characterized by degeneration of the choroid followed by photoreceptor degeneration . Defects in Rab8 trafficking have been documented in Bardet-Biedl syndrome, a cilliopathy characterized by developmental defects including degeneration of the photoreceptors [53, 54]. The association between vesicular trafficking defects and retinal degenerative disease is consistent with the early pathology observed in the rd1 mouse. PRA1 has been proposed to regulate the recruitment of Rab effector proteins as well as proteins involved in proper tethering and fusion of vesicles to their target membrane, such as VAMP2 [12, 55]. A defect in recruitment by PRA1 of Rab effectors and proteins involved in the downstream events of vesicular trafficking could correlate to the defects in vesicular trafficking reported in rd1 retinas [17, 56].
Alternatively, Figueroa and colleagues  have proposed that PRA1 could act as a chaperone protein to shuttle small GTPases through cells to their target locations. PRA1 was found to bind to other small prenylated GTPases besides Rabs, including RhoA, a small GTPase involved in actin remodeling, and K-Ras and H-Ras, small GTPases involved in cell growth, differentiation, and survival [14, 57]. For K-Ras, the rate of dissociation from the plasma membrane has been shown to be reduced or enhanced by knockdown or overexpression of PRA1, respectively . As with defects in vesicular trafficking, a defect in shuttling small GTPases required for differentiation throughout photoreceptors could correlate to the early pathology observed in the rd1 mouse retina.
In summary, our results are consistent with the hypothesis that Pde6β may have a function during photoreceptor development distinct from its phototransduction role in mature OS. Our data demonstrate a significant downregulation in Rabac1 gene expression and in PRA1 protein expression by P2 in the rd1 retina. These data support the hypothesis that PRA1 plays an important role in organization of the Golgi and vesicular trafficking during the early stages of rod photoreceptor cell differentiation and suggest that the decrease in PRA1 expression in the rd1 retina may serve as a link coupling the genetic mutation in Pde6b to the very early defects in membrane trafficking and the delay in rod photoreceptor cell differentiation that are subsequently followed by cell death. The interaction of Pde6β and cGMP signaling pathways with PRA1 is an important area for future investigation.
Mice homozygous for either the wt allele or the retinal degeneration 1/light ear (rd1/le) linked mutations on a C57BL/6 background were used for these experiments. Runts or noticeably underdeveloped pups were excluded. Animal colonies were housed in 12/12 light/dark conditions and were handled by the same staff throughout the period of microarray sample collection. Animals were handled in accordance with the National Institutes of Health Guidelines on Laboratory Animal Welfare using procedures that were approved by the Saint Louis University Institutional Animal Care and Use Committee.
Microarray and PCR sample collection
All dissections for microarray were performed by the same investigator. Retinal samples were harvested from both rd1/le and wt animals at postnatal days 2, 4, 6, and 8 for microarray. Pups were anesthetized on ice and decapitated. Tissue was maintained on ice while the eyes were enucleated. Retinas were rapidly isolated and frozen in a sterile microcentrifuge tube on dry ice. Each sample included 8–14 retinas. At least ten samples were harvested at each time point.
Total RNA was harvested from flash-frozen retina tissue using TRIzol (Invitrogen, Carlsbad, CA) extraction followed by cleanup with the RNeasy kit (Qiagen, Germantown, MD). Ten micrograms of total RNA was used for cDNA synthesis. A T7-(dT)24 oligomer, superscript reverse transcriptase II and DNA Polymerase I (Gibco BRL, Gaithersberg, MD) were used for first-strand and second-strand cDNA synthesis. Double-stranded cDNA was cleaned with Phase Lock Gels-Phenol/Chloroform extraction and ethanol precipitation. Biotin-labeled antisense cRNA was produced by an in vitro transcription reaction (ENZO BioArray High Yield RNA Transcript Labeling Kit, Farmingdale, NY). Fifteen micrograms of cRNA was incubated with fragmentation buffer (Tris-acetate, KOAc and MgOAcat; 94°C for 35 min). Target hybridization to MOE430A Gene Chips was performed using the standard Affymetrix Eukaryotic Target Hybridization protocol [58, 59]. Washing and staining were performed using the EukGE-W2v4_400 protocol [58, 59] and scanning was performed using Affymetrix GeneArray 2500.
All microarray data is MIAME compliant. Raw data have been deposited in the NCBI GEO database (accession #GSE41821). Expression scores were obtained using Robust Multichip Average to do background correction, quantile normalization and summarization . Normalized data was subjected to a two-stage analysis based on FDR-CI [61, 62] to obtain differentially expressed genes that met the minimum fold change criteria of 1.5. This two-stage algorithm allows simultaneous control of biological significance measured by fold change and statistical significance measured by FDR adjusted p-values.
Quantitative real-time PCR
Total RNA was extracted using TRIzol (Invitrogen) followed by further purification using RNeasy (Qiagen). Reverse transcription was performed using 2.5 μg of total RNA and Superscript II reverse transcriptase (Invitrogen). qPCR was performed in triplicate with the iCycler IQ system (Bio-Rad, Hercules, CA) using Sybr Green I (Invitrogen). qPCR normalization was performed using the housekeeping gene hypoxanthine guanine phosphoribosyl transferase (HPRT).
Retinal tissue was rapidly dissected and 2–8 retinas were pooled in RIPA buffer with protease inhibitors (1X TBS, 1% NP-40, 0.25% Na deoxycholate, 1 mM EDTA, 1% protease inhibitor cocktail (Sigma P8340, St. Louis, MO), 1% phosphatase inhibitor cocktail (Sigma P2850), and 1mM PMSF), flash frozen on dry ice, followed by sonication. Samples were spun at 13,000 rpm at 4°C for 10 min. Protein content of the supernatant was determined using the BCA Protein Assay (Pierce, Rockford, IL). Samples of either 6.5 or 15.8 μg/lane were electrophoresed on 4-20% Precise Protein gels (ThermoFisher, Waltham, MA) according to manufacturer's recommendations. Proteins were transferred to nitrocellulose membranes and blocked for 1 hour at room temperature in 5% nonfat dry milk in TBST. Membranes were then probed with a primary antibody to PRA1 (Proteintech Group, Chicago, IL; 1:500) overnight at 4°C. Protein was visualized using HRP-conjugated anti-rabbit IgG secondary antibody (Cell Signaling Technology, Danvers, MA; 1:6000) and enhanced chemiluminesence reagents (Sigma). Blots were stripped in 0.2M NaOH and probed with a primary antibody to β-actin (Abcam, Cambridge, MA; 1:2000) and an HRP-conjugated anti-mouse IgG secondary antibody (Santa Cruz Biotechnology, Santa Cruz, CA; 1:6000) to control for protein loading. Densitometry was performed using Image J software and represents the average of two gels.
Genotyping was performed using the RedExtract Kit (Sigma). The following primers were used: Forward 5'-TGACAATTACTCCTTTTCCCTCAGTCTG-3', rd1 reverse 5'-GTAAACAGCAAGAGGCTTTATTGGGAAC-3' and wt reverse 5'-TACCCACCCTTCCTAATTTTTCTCACGC-3' (Sigma). PCR products were separated on 1.5% agarose gels resulting in bands of approximately 400bp and 550bp for the wt and rd1 alleles, respectively.
Immunohistochemistry sample collection
Eyecups were harvested from age-matched rd1/le and wt littermates from heterozygous crosses at P6, 8, 10, and 21 and handled in the same fashion for all subsequent steps. Pups between P2-8 were anesthetized on ice and decapitated; older pups were injected intraperitoneally with an overdose of pentobarbital. Tissue was maintained on ice while the eyes were enucleated and the anterior segment was removed. Eyecups were fixed in 4% paraformaldehyde in 0.1M phosphate buffer for one hour, on ice. Following fixation, eyecups were washed 3 times for 15 minutes in 0.1M phosphate buffer and cryoprotected in 30% sucrose overnight, at 4°C. The following day, eyes were embedded in OCT (Sakura, Torrance, CA) and frozen in 2-methylbutane on dry ice. At least three samples were analyzed at each time point.
Cryostat sections were cut at a thickness of 12 μm. Each section was post-fixed with 4% paraformaldehyde in 0.1M phosphate buffer for one minute. Slides were then washed 3 times for 15 minutes in phosphate buffered saline (PBS; Sigma). All successive washes were performed in the same manner. All blocking and antibody incubations were performed in a moist chamber with each tissue section receiving 40 μl of the indicated solution. Slides were covered with parafilm during incubation. All sections were incubated in blocking solution comprised of 2% normal donkey serum (NDS, Jackson ImmunoResearch Laboratories, West Grove, PA) and 0.3% TritonX (Sigma) in PBS, for 20 minutes. Sections were incubated in polyclonal rabbit anti-PRA1 primary antibody (Proteintech Group), diluted 1:50 in blocking solution. For double label experiments, slides were concurrently incubated with monoclonal mouse anti-GM-130 (BD Bioscience, San Jose, CA), diluted 1:1000 in blocking solution; Rab6 (Santa Cruz Biotechnology, Santa Cruz, CA), diluted 1:500; or RP1 (generous gift of Eric Pierce, Massachusetts Eye and Ear Infirmary [20, 21]), diluted 1:2000. Blocking solution alone was applied as a negative control. Slides were incubated overnight at 4°C.
Slides were washed and each section was then incubated in blocking solution for 20 minutes. Sections were incubated in donkey anti-rabbit Alexa 488 secondary antibody (Molecular Probes, Eugene, OR) diluted 1:400 in blocking solution in the dark for 1 hour. For double label experiments with GM-130, slides were concurrently incubated in donkey anti-mouse Alexa 555 secondary antibody (Molecular Probes) diluted 1:400 in blocking solution. For double label experiments with RP1, slides were concurrently incubated in goat anti-chicken Alexa 555 secondary antibody (Molecular Probes) diluted 1:50 in a blocking solution with 2% NDS. Slides were washed and coverslipped with Vectashield (Vector Laboratories, Burlingame, CA) and stored at -20°C.
Confocal microscopy and analysis
Labeled sections were imaged using a Zeiss LSM 510 Meta confocal microscope. Each image consisted of a stack of slices having a thickness of 0.44 μm per slice. All images were adjusted for brightness and contrast using Image J software. All photomicrographs from a single experiment were adjusted with precisely the same settings.
Image J software was used to process and analyze images. Analysis of pixel density for regions of interest (ROI) was obtained at each developmental time point examined. First, small stacks of six slices were generated. Next, a ROI from the central and each peripheral regions of the IS layer was obtained for n = 3 eyecups of wt and rd1 age-matched littermates. Average intensity was obtained for each of the three regions of the IS layer and these values were normalized as follows: the P6 wt average intensities were arbitrarily set to one, within each pair the rd1 intensity was normalized to the wt value, and across time points the average wt values were normalized against the P6 wt value. A paired t-test was used to compare the average of rd1 IS intensity to that of wt IS. The same procedure was used to analyze intensity of the inner plexiform layer (IPL).
False Discovery Rate Confidence Interval
Ganglion cell layer
Guanine nucleotide dissociation inhibitor
GDI displacement factor
Hypoxanthine guanine phosphoribosyl transferase
Inner nuclear layer
Inner plexiform layer
cGMP phosphodiesterase 6 β-subunit
Outer nuclear layer
Outer plexiform layer
Normal donkey serum
Phosphate buffered saline
Prenylated rab acceptor 1
Quantitative real-time PCR
- Rabac1 :
Rab acceptor 1
- rd1 :
Retinal degeneration 1
Regions of interest
Hartong DT, Berson EL, Dryja TP: Retinitis pigmentosa. Lancet. 2006, 368 (9549): 1795-1809. 10.1016/S0140-6736(06)69740-7.
Daiger SP, Bowne SJ, Sullivan LS: Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol. 2007, 125 (2): 151-158. 10.1001/archopht.125.2.151.
Farber DB, Flannery JG, Bowes-Rickman C: The rd mouse story: seventy years of research on an animal model of inherited retinal degeneration. Prog Retin Eye Res. 1994, 13: 31-64. 10.1016/1350-9462(94)90004-3.
Keeler CE: The inheritance of a retinal abnormality in white mice. Proc Natl Acad Sci USA. 1924, 10 (7): 329-333. 10.1073/pnas.10.7.329.
LaVail MM, Sidman RL: C57BL-6J mice with inherited retinal degeneration. Arch Ophthalmol. 1974, 91 (5): 394-400. 10.1001/archopht.1974.03900060406015.
Ogilvie JM, Tenkova T, Lett JM, Speck J, Landgraf M, Silverman MS: Age-related distribution of cones and ON-bipolar cells in the rd mouse retina. Curr Eye Res. 1997, 16 (3): 244-251. 10.1076/ceyr.18.104.22.16811.
Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB: Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature. 1990, 347 (6294): 677-680. 10.1038/347677a0.
Pittler SJ, Baehr W: Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase ß-subunit gene of the rd mouse. Proc Natl Acad Sci USA. 1991, 88 (19): 8322-8326. 10.1073/pnas.88.19.8322.
Lolley RN, Farber DB: Abnormal guanosine 3',5'-monophosphate during photoreceptor degeneration in the inherited retinal disorder of C3H/HeJ mice. Ann Ophthalmol. 1976, 8: 469-473.
Kleppisch T, Feil R: cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour. Handb Exp Pharmacol. 2009, 191: 549-579. 10.1007/978-3-540-68964-5_24.
Bucci C, Chiariello M, Lattero D, Maiorano M, Bruni CB: Interaction cloning and characterization of the cDNA encoding the human prenylated rab acceptor (PRA1). Biochem Biophys Res Commun. 1999, 258 (3): 657-662. 10.1006/bbrc.1999.0651.
Martincic I, Peralta ME, Ngsee JK: Isolation and characterization of a dual prenylated Rab and VAMP2 receptor. J Biol Chem. 1997, 272 (43): 26991-26998. 10.1074/jbc.272.43.26991.
Janoueix-Lerosey I, Jollivet F, Camonis J, Marche PN, Goud B: Two-hybrid system screen with the small GTP-binding protein Rab6. Identification of a novel mouse GDP dissociation inhibitor isoform and two other potential partners of Rab6. J Biol Chem. 1995, 270 (24): 14801-14808. 10.1074/jbc.270.24.14801.
Figueroa C, Taylor J, Vojtek AB: Prenylated Rab acceptor protein is a receptor for prenylated small GTPases. J Biol Chem. 2001, 276 (30): 28219-28225. 10.1074/jbc.M101763200.
Cavusoglu N, Thierse D, Mohand-Said S, Chalmel F, Poch O, Van-Dorsselaer A, Sahel JA, Leveillard T: Differential proteomic analysis of the mouse retina: the induction of crystallin proteins by retinal degeneration in the rd1 mouse. Mol Cell Proteomics. 2003, 2 (8): 494-505.
Jones SE, Jomary C, Grist J, Thomas MR, Neal MJ: Expression of alphaB-crystallin in a mouse model of inherited retinal degeneration. Neuroreport. 1998, 9 (18): 4161-4165. 10.1097/00001756-199812210-00030.
Sanyal S, Bal AK: Comparative light and electron microscopic study of retinal histogenesis in normal and rd mutant mice. Z Anat Entwicklungsgesch. 1973, 142 (2): 219-238. 10.1007/BF00519723.
Deretic D: Rab proteins and post-Golgi trafficking of rhodopsin in photoreceptor cells. Electrophoresis. 1997, 18 (14): 2537-2541. 10.1002/elps.1150181408.
Barr FA, Short B: Golgins in the structure and dynamics of the Golgi apparatus. Curr Opin Cell Biol. 2003, 15 (4): 405-413. 10.1016/S0955-0674(03)00054-1.
Liu Q, Zhou J, Daiger SP, Farber DB, Heckenlively JR, Smith JE, Sullivan LS, Zuo J, Milam AH, Pierce EA: Identification and subcellular localization of the RP1 protein in human and mouse photoreceptors. Invest Ophthalmol Vis Sci. 2002, 43 (1): 22-32.
Liu Q, Zuo J, Pierce EA: The retinitis pigmentosa 1 protein is a photoreceptor microtubule-associated protein. J Neurosci: the official journal of the Society for Neuroscience. 2004, 24 (29): 6427-6436. 10.1523/JNEUROSCI.1335-04.2004.
Marigo V: Programmed cell death in retinal degeneration: targeting apoptosis in photoreceptors as potential therapy for retinal degeneration. Cell Cycle. 2007, 6 (6): 652-655. 10.4161/cc.6.6.4029.
Blanks JC, Adinolfi AM, Lolley RN: Photoreceptor degeneration and synaptogenesis in retinal-degenerative (rd) mice. J Comp Neurol. 1974, 156 (1): 95-106. 10.1002/cne.901560108.
Caley DW, Johnson C, Liebelt RA: The postnatal development of the retina in the normal and rodless CBA mouse: a light and electron microscopic study. Am J Anat. 1972, 133 (2): 179-212. 10.1002/aja.1001330205.
Rohrer B, Pinto FR, Hulse KE, Lohr HR, Zhang L, Almeida JS: Multidestructive pathways triggered in photoreceptor cell death of the rd mouse as determined through gene expression profiling. J Biol Chem. 2004, 279 (40): 41903-41910. 10.1074/jbc.M405085200.
Demos C, Bandyopadhyay M, Rohrer B: Identification of candidate genes for human retinal degeneration loci using differentially expressed genes from mouse photoreceptor dystrophy models. Mol Vis. 2008, 14: 1639-1649.
Hackam AS, Strom R, Liu D, Qian J, Wang C, Otteson D, Gunatilaka T, Farkas RH, Chowers I, Kageyama M, et al: Identification of gene expression changes associated with the progression of retinal degeneration in the rd1 mouse. Invest Ophthalmol Vis Sci. 2004, 45 (9): 2929-2942. 10.1167/iovs.03-1184.
Fox DA, Poblenz AT, He L: Calcium Overload Triggers Rod Photoreceptor Apoptotic Cell Death in Chemical-Induced and Inherited Retinal Degenerations. Ann N Y Acad Sci. 1999, 893: 282-285. 10.1111/j.1749-6632.1999.tb07837.x.
Doonan F, Donovan M, Cotter TG: Activation of multiple pathways during photoreceptor apoptosis in the rd mouse. Invest Ophthalmol Vis Sci. 2005, 46 (10): 3530-3538. 10.1167/iovs.05-0248.
Paquet-Durand F, Beck S, Michalakis S, Goldmann T, Huber G, Muhlfriedel R, Trifunovic D, Fischer MD, Fahl E, Duetsch G, et al: A key role for cyclic nucleotide gated (CNG) channels in cGMP-related retinitis pigmentosa. Hum Mol Genet. 2011, 20 (5): 941-947. 10.1093/hmg/ddq539.
Tosi J, Davis RJ, Wang NK, Naumann M, Lin CS, Tsang SH: shRNA knockdown of guanylate cyclase 2e or cyclic nucleotide gated channel alpha 1 increases photoreceptor survival in a cGMP phosphodiesterase mouse model of retinitis pigmentosa. J Cell Mol Med. 2011, 15 (8): 1778-1787. 10.1111/j.1582-4934.2010.01201.x.
Bibb LC, Holt JK, Tarttelin EE, Hodges MD, Gregory-Evans K, Rutherford A, Lucas RJ, Sowden JC, Gregory-Evans CY: Temporal and spatial expression patterns of the CRX transcription factor and its downstream targets. Critical differences during human and mouse eye development. Hum Mol Genet. 2001, 10 (15): 1571-1579. 10.1093/hmg/10.15.1571.
Godfrey EW, Schwarte RC: The role of nitric oxide signaling in the formation of the neuromuscular junction. J Neurocytol. 2003, 32 (5–8): 591-602.
Keynes RG, Garthwaite J: Nitric oxide and its role in ischaemic brain injury. Curr Mol Med. 2004, 4 (2): 179-191. 10.2174/1566524043479176.
Packer MA, Stasiv Y, Benraiss A, Chmielnicki E, Grinberg A, Westphal H, Goldman SA, Enikolopov G: Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci USA. 2003, 100 (16): 9566-9571. 10.1073/pnas.1633579100.
Serulle Y, Arancio O, Ziff EB: A role for cGMP-dependent protein kinase II in AMPA receptor trafficking and synaptic plasticity. Channels (Austin). 2008, 2 (4): 230-232. 10.4161/chan.2.4.6391.
Pilz RB, Broderick KE: Role of cyclic GMP in gene regulation. Front Biosci. 2005, 10: 1239-1268. 10.2741/1616.
Paquet-Durand F, Hauck SM, van Veen T, Ueffing M, Ekstrom P: PKG activity causes photoreceptor cell death in two retinitis pigmentosa models. J Neurochem. 2009, 108 (3): 796-810. 10.1111/j.1471-4159.2008.05822.x.
Zhang X, Cote RH: cGMP signaling in vertebrate retinal photoreceptor cells. Front Biosci. 2005, 10: 1191-1204. 10.2741/1612.
Liang Z, Li G: Mouse prenylated Rab acceptor is a novel Golgi membrane protein. Biochem Biophys Res Commun. 2000, 275 (2): 509-516. 10.1006/bbrc.2000.3316.
Lin J, Liang Z, Zhang Z, Li G: Membrane topography and topogenesis of prenylated Rab acceptor (PRA1). J Biol Chem. 2001, 276 (45): 41733-41741. 10.1074/jbc.M103475200.
Hutt DM, Da-Silva LF, Chang LH, Prosser DC, Ngsee JK: PRA1 inhibits the extraction of membrane-bound rab GTPase by GDI1. J Biol Chem. 2000, 275 (24): 18511-18519. 10.1074/jbc.M909309199.
Sivars U, Aivazian D, Pfeffer SR: Yip3 catalyses the dissociation of endosomal Rab-GDI complexes. Nature. 2003, 425 (6960): 856-859. 10.1038/nature02057.
Liu HP, Wu CC, Kao HY, Huang YC, Liang Y, Chen CC, Yu JS, Chang YS: Proteome-wide dysregulation by PRA1 depletion delineates a role of PRA1 in lipid transport and cell migration. Mol Cell Proteomics. 2011, 10 (3): M900641MCP900200.
Compton SL, Behrend EN: PRAF1: a Golgi complex transmembrane protein that interacts with viruses. Biochem Cell Biol. 2006, 84 (6): 940-948. 10.1139/o06-176.
Liu HP, Wu CC, Chang YS: PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1. EMBO J. 2006, 25 (17): 4120-4130. 10.1038/sj.emboj.7601282.
Li LY, Shih HM, Liu MY, Chen JY: The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction. J Biol Chem. 2001, 276 (29): 27354-27362. 10.1074/jbc.M103821200.
Evans DT, Tillman KC, Desrosiers RC: Envelope glycoprotein cytoplasmic domains from diverse lentiviruses interact with the prenylated Rab acceptor. J Virol. 2002, 76 (1): 327-337. 10.1128/JVI.76.1.327-337.2002.
Enouf V, Chwetzoff S, Trugnan G, Cohen J: Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1. J Virol. 2003, 77 (12): 7041-7047. 10.1128/JVI.77.12.7041-7047.2003.
Kwok MC, Holopainen JM, Molday LL, Foster LJ, Molday RS: Proteomics of photoreceptor outer segments identifies a subset of SNARE and Rab proteins implicated in membrane vesicle trafficking and fusion. Mol Cell Proteomics. 2008, 7 (6): 1053-1066. 10.1074/mcp.M700571-MCP200.
Liu Q, Tan G, Levenkova N, Li T, Pugh EN, Rux JJ, Speicher DW, Pierce EA: The proteome of the mouse photoreceptor sensory cilium complex. Mol Cell Proteomics. 2007, 6 (8): 1299-1317. 10.1074/mcp.M700054-MCP200.
Alory C, Balch WE: Organization of the Rab-GDI/CHM superfamily: the functional basis for choroideremia disease. Traffic. 2001, 2 (8): 532-543. 10.1034/j.1600-0854.2001.20803.x.
Nachury MV, Loktev AV, Zhang Q, Westlake CJ, Peranen J, Merdes A, Slusarski DC, Scheller RH, Bazan JF, Sheffield VC, et al: A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell. 2007, 129 (6): 1201-1213. 10.1016/j.cell.2007.03.053.
Zaghloul NA, Katsanis N: Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J Clin Invest. 2009, 119 (3): 428-437. 10.1172/JCI37041.
Gougeon PY, Prosser DC, Da-Silva LF, Ngsee JK: Disruption of Golgi morphology and trafficking in cells expressing mutant prenylated rab acceptor-1. J Biol Chem. 2002, 277 (39): 36408-36414. 10.1074/jbc.M205026200.
Lasansky A, DeRobertis E: Submicroscopic analysis of the genetic distrophy of visual cells in C3H mice. J Biophys Biochem Cy. 1960, 7: 679-683. 10.1083/jcb.7.4.679.
Bhagatji P, Leventis R, Rich R, Lin CJ, Silvius JR: Multiple cellular proteins modulate the dynamics of K-ras association with the plasma membrane. Biophys J. 2010, 99 (10): 3327-3335. 10.1016/j.bpj.2010.10.001.
Nagaraja GM, Othman M, Fox BP, Alsaber R, Pellegrino CM, Zeng Y, Khanna R, Tamburini P, Swaroop A, Kandpal RP: Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene. 2006, 25 (16): 2328-2338. 10.1038/sj.onc.1209265.
Rozsa FW, Reed DM, Scott KM, Pawar H, Moroi SE, Kijek TG, Krafchak CM, Othman MI, Vollrath D, Elner VM, et al: Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. Mol Vis. 2006, 12: 125-141.
Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31 (4): e15-10.1093/nar/gng015.
Benjamini Y, Yekutieli D: Quantitative trait Loci analysis using the false discovery rate. Genetics. 2005, 171 (2): 783-790. 10.1534/genetics.104.036699.
Hero AO, Fleury G, Mears AJ, Swaroop A: Multicriteria gene screening for analysis of differential expression with DNA microarrays. EURASIP JASP. 2004, 1: 43-52.
We would like to thank Sepideh Zareparsi, Judy Speck, Rebecca Gunkel, Garrett Searcy, Ju Zhang, and Cynthia Montana for helpful suggestions and technical support. We would also like to thank Eric Pierce for the generous gift of the RP1 antibody. This research was supported by individual grants from the National Institutes of Health, http://grants.nih.gov/grants/oer.htm (EY15113, HD064269, JMO), and the Foundation Fighting Blindness, http://www.blindness.org/ (JMO), an equipment grant from the National Science Foundation, http://www.nsf.gov/ (DBI-0421383), and intramural program of the National Eye Institute.
The authors declare that they have no competing interests.
Conceived and designed the experiments: VMD, AMR, AJM, AS, JMO. Performed the experiments: VMD, AMR, JGM, SCEH, AAI, AYC, MJB, MIO, JMO. Analyzed the data: VMD, AMR, RK, AJM, AS, JMO. Wrote the paper: VMD, AMR, JMO. All authors read and approved the final manuscript.
Virginia M Dickison, Angela M Richmond contributed equally to this work.
Electronic supplementary material
Additional file 1: Table S1: includes the 143 genes that showed significant differential expression by microarray analysis in rd1 compared to wt retina for one or more time points. Table S2. includes the eighteen genes that were analyzed by qPCR. Microarray analysis of fold-change is indicated in the final column for comparison. (XLS 68 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Dickison, V.M., Richmond, A.M., Abu Irqeba, A. et al. A role for prenylated rab acceptor 1 in vertebrate photoreceptor development. BMC Neurosci 13, 152 (2012). https://doi.org/10.1186/1471-2202-13-152
- Retinal degeneration
- Photoreceptor development
- Prenylated Rab Acceptor 1
- Vesicular trafficking